MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients

Background. MicroRNAs (miRNAs) have been demonstrated to exhibit important regulatory roles in multiple malignancies, including hepatocellular carcinoma (HCC). hsa-miR-497-5p was reported to involve in cancer progression and poor prognosis in many kinds of tumors. However, the expression and its cli...

Full description

Saved in:
Bibliographic Details
Main Authors: Lin-Lin Tian, Bin Qian, Xiao-Hui Jiang, Yu-Shan Liu, Tong Chen, Cheng-You Jia, Ya-Li Zhou, Ji-Bin Liu, Yu-Shui Ma, Da Fu, Sen-Tai Ding
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2021/6670390
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849407105854865408
author Lin-Lin Tian
Bin Qian
Xiao-Hui Jiang
Yu-Shan Liu
Tong Chen
Cheng-You Jia
Ya-Li Zhou
Ji-Bin Liu
Yu-Shui Ma
Da Fu
Sen-Tai Ding
author_facet Lin-Lin Tian
Bin Qian
Xiao-Hui Jiang
Yu-Shan Liu
Tong Chen
Cheng-You Jia
Ya-Li Zhou
Ji-Bin Liu
Yu-Shui Ma
Da Fu
Sen-Tai Ding
author_sort Lin-Lin Tian
collection DOAJ
description Background. MicroRNAs (miRNAs) have been demonstrated to exhibit important regulatory roles in multiple malignancies, including hepatocellular carcinoma (HCC). hsa-miR-497-5p was reported to involve in cancer progression and poor prognosis in many kinds of tumors. However, the expression and its clinical significance of hsa-miR-497-5p in HCC remain unclear. Methods. In the present study, we investigated the expression of hsa-miR-497-5p in HCC and analyzed the correction of clinical features with prognosis. The expression levels of hsa-miR-497-5p and potential target genes were analyzed in HCC and adjacent noncancerous tissues using The Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus (GEO) datasets. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to analyze hsa-miR-497-5p levels in 328 HCC tissues and 30 paired adjacent noncancer tissues. Overall survival (OS) and progression-free survival (PFS) of patients with HCC were assessed using the Kaplan-Meier method and the log-rank test. Results. The hsa-miR-497-5p expression levels were decreased, and its target genes ACTG1, CSNK1D, PPP1CC, and BIRC5 were upregulated in HCC tissues compared with normal tissues. Lower levels of hsa-miR-497-5p expression and higher levels of the four target genes were significantly associated with higher tumor diameter. Moreover, patients with lower hsa-miR-497-5p expression and higher target genes levels had shorter OS. Conclusion. The expression levels of hsa-miR-497-5p may play an important regulatory role in HCC and are closely correlated with HCC progression and poor prognosis in patients. The hsa-miR-497-5p may be a specific therapeutic target for the treatment of HCC.
format Article
id doaj-art-459aa2d1992f44ebbb9e539b1e3b57c9
institution Kabale University
issn 2314-436X
2314-4378
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-459aa2d1992f44ebbb9e539b1e3b57c92025-08-20T03:36:11ZengWileyInternational Journal of Genomics2314-436X2314-43782021-01-01202110.1155/2021/66703906670390MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in PatientsLin-Lin Tian0Bin Qian1Xiao-Hui Jiang2Yu-Shan Liu3Tong Chen4Cheng-You Jia5Ya-Li Zhou6Ji-Bin Liu7Yu-Shui Ma8Da Fu9Sen-Tai Ding10Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, ChinaDepartment of General Surgery, Shanghai Eighth People’s Hospital, Shanghai 200235, ChinaDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital of Nantong University, Nantong 226631, ChinaDepartment of Pathology, Nantong Tumor Hospital, Nantong 226631, ChinaDepartment of Pediatric Surgery, Shanghai Children’s Hospital, Shanghai Jiao Tong University, ChinaCentral Laboratory for Medical Research, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Microbiology, Faculty of Basic Medical Sciences, Guilin Medical University, Guilin 541001, ChinaDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital of Nantong University, Nantong 226631, ChinaCentral Laboratory for Medical Research, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaCentral Laboratory for Medical Research, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaDepartment of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, ChinaBackground. MicroRNAs (miRNAs) have been demonstrated to exhibit important regulatory roles in multiple malignancies, including hepatocellular carcinoma (HCC). hsa-miR-497-5p was reported to involve in cancer progression and poor prognosis in many kinds of tumors. However, the expression and its clinical significance of hsa-miR-497-5p in HCC remain unclear. Methods. In the present study, we investigated the expression of hsa-miR-497-5p in HCC and analyzed the correction of clinical features with prognosis. The expression levels of hsa-miR-497-5p and potential target genes were analyzed in HCC and adjacent noncancerous tissues using The Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus (GEO) datasets. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to analyze hsa-miR-497-5p levels in 328 HCC tissues and 30 paired adjacent noncancer tissues. Overall survival (OS) and progression-free survival (PFS) of patients with HCC were assessed using the Kaplan-Meier method and the log-rank test. Results. The hsa-miR-497-5p expression levels were decreased, and its target genes ACTG1, CSNK1D, PPP1CC, and BIRC5 were upregulated in HCC tissues compared with normal tissues. Lower levels of hsa-miR-497-5p expression and higher levels of the four target genes were significantly associated with higher tumor diameter. Moreover, patients with lower hsa-miR-497-5p expression and higher target genes levels had shorter OS. Conclusion. The expression levels of hsa-miR-497-5p may play an important regulatory role in HCC and are closely correlated with HCC progression and poor prognosis in patients. The hsa-miR-497-5p may be a specific therapeutic target for the treatment of HCC.http://dx.doi.org/10.1155/2021/6670390
spellingShingle Lin-Lin Tian
Bin Qian
Xiao-Hui Jiang
Yu-Shan Liu
Tong Chen
Cheng-You Jia
Ya-Li Zhou
Ji-Bin Liu
Yu-Shui Ma
Da Fu
Sen-Tai Ding
MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
International Journal of Genomics
title MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
title_full MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
title_fullStr MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
title_full_unstemmed MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
title_short MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
title_sort microrna 497 5p is downregulated in hepatocellular carcinoma and associated with tumorigenesis and poor prognosis in patients
url http://dx.doi.org/10.1155/2021/6670390
work_keys_str_mv AT linlintian microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT binqian microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT xiaohuijiang microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT yushanliu microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT tongchen microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT chengyoujia microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT yalizhou microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT jibinliu microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT yushuima microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT dafu microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients
AT sentaiding microrna4975pisdownregulatedinhepatocellularcarcinomaandassociatedwithtumorigenesisandpoorprognosisinpatients